Handbook of Clinical medicine
KEYWORDS: patient, disease, patients, history, pain, heart, symptoms, ask, time, treatment, risk, examination, aortic, iinnddbb, pulse

Mycobacterium leprae which aff ects skin, nerves, and mucous membranes. Incubation 5–20y. Transmitted via droplets from nose/mouth during close and frequent contact. Classifi ed as: • Multibacillary (‘lepromatous’): immune response, bacilli, +ve smear. • Paucibacillary (‘tuberculoid’): immune response, granulomata with bacilli, smears may be Ωve. Free treatment through WHO since 1995: prevalence  by 99% to 176 000 in 2014 (5.2 million in 1985).12 Presentation: Hypopigment- ed skin lesions (fi g 9.58, less well demarcated than vitiligo), sensory loss, thickened nerves, nodules, plaques, nasal congestion, epistaxis, muscle weakness, paralysis, neuropathic ul- cers. Eye involvement: chronic iritis, scleritis, episcleritis, corneal sensation (V nerve palsy), blinking and lagophthalmos (VII nerve palsy), trauma from eyelashes (trichiasis). Diagnosis: Clinical, +ve skin smear, skin biopsy. Serology unreliable. Treatment: WHO multidrug therapy: • Multibacillary: Rifampicin 600mg/month, Fig 9.58 Leprosy: hypopigmented mac- dapsone 100mg OD, clofazimine 300mg/month ules. Courtesy of Prof. Jayakar Thoma. and 50mg OD. Duration: 1yr. • Paucibacillary: rifampicin 600mg/month, dapsone 100mg OD. Duration: 6 months. If single lesion: rifampicin 600mg+ofl oxacin 400mg+minocycline 100mg (single dose). Yaws Chronic granulomatous disease caused byTreponema pertenue. Found in humid/rainforest areas in Africa, Asia, Latin American, Pacifi c. Associated with socio- economic conditions. Transmission via direct contact. Presentation: Primary
